Abstract
The effects of atenolol, a new beta1-blocking drug, on pulse rate, sweating, and blood glucose levels during insulin-induced hypoglycaemia were studied in a double-blind crossover trial in eight normal subjects using placebo and propranolol as reference agents. The intensity of induced hypoglycaemia was identical for atenolol, propranolol, and placebo. Propranolol prolonged hypoglycaemia, but atenolol did not. Atenolol may therefore be safe for use in patients receiving insulin.
MeSH Terms
Adrenergic beta-Antagonists/pharmacology
Adult
Atenolol/pharmacology
Blood Glucose
Clinical Trials as Topic
Depression, Chemical
Heart Rate/drug effects
Humans
Hypoglycemia/chemically induced
Insulin/pharmacology
Male
Placebos
Propanolamines/pharmacology
Propranolol/pharmacology
Pulse/drug effects
Sweating/drug effects
Time Factors
Chemicals
Adrenergic beta-Antagonists
Blood Glucose
Insulin
Placebos
Propanolamines
Atenolol
Propranolol
Authors & Affiliations
2 authors, click to expand affiliations / ORCID
Deacon S P
Barnett D
References (5)
5 references, click to expand
-
Hypoglycemia: a potent stimulus to secretion of growth hormone.
Science. 1963 May 31;140(3570):987-8
PMID: 13975313
-
THE ADRENOCORTICAL RESPONSE TO INSULIN-INDUCED HYPOGLYCAEMIA.
J Endocrinol. 1963 Nov;27:183-92
PMID: 14079508
-
Effects of propranolol on the hormonal and metabolic responses to insulin-induced hypoglycaemia.
Lancet. 1966 Dec 24;2(7478):1386-8
PMID: 4163545
-
Propranolol-induced hypoglycaemia and myocardial infarction.
Br Med J. 1972 Jun 3;2(5813):592
PMID: 5032795
-
Once-daily dosing with Atenolol in patients with mild or moderate hypertension.
Br Med J. 1976 Apr 24;1(6016):990-1
PMID: 773494